MSB 0_o, page-44

Contracts aren't set in stone. There are always procedures for termination. Teva has made and continues to make, commercial decisions about proceeding in support and partnership with MSB.

In Australia hardly any of our large companies have patents or many patents and none are relying on patents as part of their market strategy so of the top 20 companies in Australia none of them have patents that are core to their business. This makes it difficult for Australia to be an inventive or innovative nation. - listen to Ian Maxwell, adjunct Professor at RMIT being interviewed by Amanda Vanstone on Counterpoint on ABC RN
http://www.abc.net.au/radionational/programs/counterpoint/national-invention-system3f/5786148

Quite obviously, not many financial analysts here understand the business models, and I'd suggest their understanding is far inferior to the one that Teva has as a Big Pharma, regardless of what anyone who wants to talk the SP down says. This is also because Teva has access to information that the market doesn't have.

This is why it is annoying that various downrampers will keep banging on about the SP as if it means the market has brilliant understanding.
Simply put, no it doesn't.